Item 9 Labs Corp.
INLB · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Market Cap | $37,798 | $124,963 | $92,433 | $171,674 |
| - Cash | $86 | $1,454 | $85 | $21 |
| + Debt | $27,845 | $20,932 | $7,944 | $4,772 |
| Enterprise Value | $65,557 | $144,440 | $100,292 | $176,424 |
| Revenue | $21,757 | $21,937 | $8,122 | $4,934 |
| % Growth | -0.8% | 170.1% | 64.6% | – |
| Gross Profit | $7,312 | $8,613 | $3,296 | $2,378 |
| % Margin | 33.6% | 39.3% | 40.6% | 48.2% |
| EBITDA | -$22,829 | -$4,350 | -$4,447 | -$8,930 |
| % Margin | -104.9% | -19.8% | -54.8% | -181% |
| Net Income | -$31,143 | -$10,906 | -$12,300 | -$10,631 |
| % Margin | -143.1% | -49.7% | -151.4% | -215.5% |
| EPS Diluted | -0.33 | -0.14 | -0.2 | -0.17 |
| % Growth | -135.7% | 30% | -17.6% | – |
| Operating Cash Flow | -$2,254 | -$5,990 | -$1,141 | -$2,393 |
| Capital Expenditures | -$5,458 | -$2,242 | -$406 | -$6,458 |
| Free Cash Flow | -$7,713 | -$8,232 | -$1,548 | -$8,851 |